FDA Investigator Nicholas Obiri, PhD

Nicholas Obiri, PhD has conducted inspections on 6 sites in 3 countries as of 09 Jul 2001. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
6
Last Inspection Date:
09 Jul 2001
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Puerto Rico, United States of America, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Nicholas Obiri, PhD:
Adaliz Santaliz Cruz, Aikaterini Alexaki, Alan A Rivera, Amalia C Himaya, Andrea A Branche, Andrea George, PhD, Angel K Sandhu, Angela K Shen, Anh M Lac, Anissa M Cheung, Anita Narula, PhD, Arlene M Badillo, Ashley N Queen, PhD, Barbara J Wilcox, PhD, Barry Cherney, PhD, Bichsa T Tran, Bo Chi, PhD, Brien C Fox, Burnell M Henry, Calvin B Koerner, Carl Lee, Carla J Lundi, Carole L Jones, Caryn M Everly, Caryn M Mcnab, Cassandra Overking, Chava Kimchi Sarfaty, PhD, Cheron M Portee, Christina C Santos, Christina V Santos, Christopher Downey, PhD, Christopher R Czajka, Colleen Thomas, PhD, Cynthia Jim, CSO, Daniel J Roberts, Daniel W Cline, David S Cho, PhD, Davinna Ligons, PhD, Dennis Cantellops Paite, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Dov H Pluznik, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Dustin R Abaonza, Eileen A Liu, Eliezar Ramos, Emily Shacter, Eric L Dong, BS, Erika V Butler, Esther C Broner, PhD, Frances Namuswe, PhD, Gene D Arcy, Gerald Feldman, Gerald M Feldman, PhD, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Henry K Lau, Iris C Macinnes, Ivis L Negron, J David Doleski, Jacqueline Mdiaz Albertini, James R Evans, James R Fleckenstein, Jeanne Fringer, PhD, Jee Chung, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer Lalama, Jennifer M Gogley, Jerri Baker, Joan A Loreng, Joan T Briones, Joel Welch, PhD, Joey V Quitania, John D Finkbohner, PhD, John M Mcinnis, John M Mclnnis, John R Myung, Jorge L Lajara, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose R Lopez, Jose Velez, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Joyce A Rockwell, Junho Pak, Ka L Wong, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin P Foley, Kim Lthomas Cruse, Lakisha M Williams, Lance Mde Souza, MBA, Laura Fontan, MS, Laurie P Norwood, LCDR Jennifer H Rhyu, Leonard H Lavi, Lewis K Antwi, Libia M Lugo, Linda Thai, Linh Tu, LT Rafael Gonzalez, Mabel M Lee, Maida Henesian (NMI), Marcia B Williams, Marcus F Yambot, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marie K Kinkade, Marion Michaelis, Mariza M Jafary, Mark A Elengold, Marsha W Major, Maxwell Van Tassell, PhD, Maxyne T Lam, Michael A Charles, Michael Shanks, MS, Michael T Cyrus, Michele L Forster, PhD, Michelle A Marsh, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Milva E Melendez Perales, Min Shanmabel Liu, Mohsen Rajabi Abhari, FDA, Myriam M Sosa, Natalya M Ananyeva, Nayan J Patel, Nicholas L Hunt, Nicola M Fenty Stewart, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Paul Z Balcer, Paula A Trost, Peter E Baker, Peter Kessler, PhD, Peter S Diak, Prabhu P Raju, Ramesh Potla, PhD, Ramon A Hernandez, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Parrilla, Rebecca Rodriguez, Rebecca T Davis, Richmond K Yip, Riley C Myers, PhD, Robert D Tollefsen, Robert Darius, Robert Jennings, Robin Levis, PhD, Roger F Zabinski, Roman T Drews, PhD, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Rose Ashley, Sandra S Saniga, Sarah Arden, Scott N Lim, Scott R Nichols, PhD, Serge L Beaucage, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Simone E Pitts, Sonia R Peterson, Stanley Au, Stephanie A Slater, MS, Steven A Rubin, Steven C Madzo, Steven Fong, MS, PhD, Stuart W Russell, Susan F Laska, MS, Susan M Jackson, Susan Yu, Svetlana A Shestopal, Taichun Qin, PhD, Tamika White, Terri L Dodds, Thao T Kwan, Thao X Tran, Thea C Grome, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy C Grome, Timothy Wadkin, PhD, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Walden H Lee, Wendy G Tan, PhD, William V Millar, Yi Wang, PhD, Yumi J Hiramine, Yvonne C Wilkes, Zachary L Stamm, Zhong Li, PhD

Nicholas Obiri, PhD's Documents

Publish Date Document Type Title
May, 2001 FDA 483 Evans Vaccines Ltd. - Form 483, 2001-05-11
October, 2000 FDA 483 Amgen, Inc - Form 483, 2000-10-20
May, 2001 FDA 483 Response Seqirus Vaccines Limited - Form 483R, 2001-05-31
January, 2000 FDA 483 Genentech, Inc. - Form 483, 2000-01-14
May, 2001 EIR Seqirus Vaccines Limited - EIR, 2001-05-11
July, 2001 EIR BAXALTA US INC. - EIR, 2001-07-13
January, 2000 EIR Genentech, Inc. - EIR, 2000-01-14
October, 2000 EIR Amgen Manufacturing Limited LLC - EIR, 2000-10-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more